Deuterium

Stearic acid-d5 is intended for use as an internal standard for the quantification of stearic acid by GC- or LC-MS.

β-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation) is intended for use as an internal standard for the quantification of β-hydroxythiofentanyl by GC- or LC-MS.

1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9 LPA) is intended for use as an internal standard for the quantification of 1-palmitoyl LPA by GC- or LC-MS.

(±)-Methadone-d3 is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS.

(±)-Methadone-d3 (CRM) is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS.

Lorazepam-d4 (CRM) is intended for use as an internal standard for the quantification of lorazepam .

Etomidate-d5 is intended for use as an internal standard for the quantification of etomidate by GC- or LC-MS.

α-Pyrrolidinohexanophenone-d8 (hydrochloride) (CRM) is intended for use as an internal standard for the quantification of α-pyrrolidinohexanophenone by GC- or LC-MS.

Aeruginascin-d3 is intended for use as an internal standard for the quantification of aeruginascin by GC- or LC-MS.

Phytosphingosine-d7 is intended for use as an internal standard for the quantification of phytosphingosine by GC- or LC-MS.

9(S)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(S)-hexahydrocannabinol by GC- or LC-MS.

9(R)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(R)-hexahydrocannabinol by GC- or LC-MS.

(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS.

ADB-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-BUTINACA by GC- or LC-MS.

14(S)-HDHA-d5 is intended for use as an internal standard for the quantification of 14(S)-HDHA by GC- or LC-MS.

MDMB-BUTINACA-d9 is intended for use as an internal standard for the quantification of MDMB-BUTINACA by GC- or LC-MS.

MDMB-4en-PINACA-d4 (CRM) is intended for use as an internal standard for the quantification of MDMB-4en-PINACA in a drug discrimination test and induces hypothermia in mice.

Iloprost-d4 is intended for use as an internal standard for the quantification of iloprost by GC- or LC-MS.

MDMB-PICA-d9 is intended for use as an internal standard for the quantification of MDMB-PICA by GC- or LC-MS.

Prednisolone-d7 is intended for use as an internal standard for the quantification of prednisolone by GC- or LC-MS.

ADB-5'Br-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-5'Br-BUTINACA by GC- or LC-MS.

18-hydroxy Oleoyl leucine-d7 is intended for use as an internal standard for the quantification of 18-hydroxy oleoyl leucine by GC- or LC-MS.

1-Myristoyl-d7-2-hydroxy-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-myristoyl-2-hydroxy-sn-glycero-3-PC by GC- or LC-MS.

Oleic acid-hydroxy oleoyl leucine-d7 is intended for use as an internal standard for the quantification of oleic acid-hydroxy oleoyl leucine by GC- or LC-MS.